Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical's First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided ...

-- Peer-reviewed data published in Neurosurgery show that SOLOPASS (R) 2.0 delivers significantly higher accuracy than free-hand EVD placement. -- SOLOPASS (R) 2.0 achieved consistent accuracy across ...
Business Wire

BioVentrix Receives 2021 NUB Status 1 Reimbursement Renewal in Germany for the Revivent TC TransCatheter Ventricular Enhancement System

SAN RAMON, Calif.--(BUSINESS WIRE)--BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure (CHF) via Transcatheter based Ventricular Restoration (TCVR), ...